Sivik Global Healthcare’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.26M | Hold |
15,000
| – | – | 2.48% | 22 |
|
|
2026
Q1 | $3.26M | Sell |
15,000
-5,000
| -25% | -$1.11M | 2.48% | 22 |
|
|
2025
Q4 | $4.57M | Hold |
20,000
| – | – | 1.33% | 25 |
|
|
2025
Q3 | $4.63M | Buy |
+20,000
| New | +$4.07M | 1.35% | 30 |
|
|
2025
Q1 | – | Sell |
-25,000
| Closed | -$4.44M | – | 32 |
|
|
2024
Q4 | $4.44M | Buy |
+25,000
| New | +$4.6M | 2.34% | 20 |
|
|
2023
Q2 | – | Sell |
-40,000
| Closed | -$6.38M | – | 45 |
|
|
2023
Q1 | $6.38M | Buy |
+40,000
| New | +$6.12M | 2.74% | 15 |
|
|
2022
Q2 | – | Sell |
-20,000
| Closed | -$3.24M | – | 39 |
|
|
2022
Q1 | $3.24M | Sell |
20,000
-20,000
| -50% | -$2.91M | 1.34% | 35 |
|
|
2021
Q4 | $5.42M | Buy |
+40,000
| New | +$4.73M | 2.32% | 20 |
|
|
2021
Q3 | – | Sell |
-20,000
| Closed | -$2.25M | – | 45 |
|
|
2021
Q2 | $2.25M | Buy |
+20,000
| New | +$2.25M | 0.44% | 43 |
|
|
2020
Q3 | – | Sell |
-13,000
| Closed | -$5.87M | – | 39 |
|
|
2020
Q2 | $5.87M | Buy |
13,000
+3,000
| +30% | +$264K | 1.94% | 21 |
|
|
2020
Q1 | $3.51M | Sell |
10,000
-40,000
| -80% | -$3.41M | 1.38% | 34 |
|
|
2019
Q4 | $4.43M | Buy |
+50,000
| New | +$4.15M | 1.64% | 33 |
|
|
2019
Q2 | – | Sell |
-42,500
| Closed | -$3.42M | – | 61 |
|
|
2019
Q1 | $3.42M | Buy |
+42,500
| New | +$3.48M | 1.26% | 38 |
|
|
2018
Q2 | – | Sell |
-75,000
| Closed | -$7.1M | – | 62 |
|
|
2018
Q1 | $7.1M | Buy |
75,000
+10,000
| +15% | +$1.1M | 3.31% | 4 |
|
|
2017
Q4 | $6.29M | Sell |
65,000
-30,000
| -32% | -$2.83M | 2.33% | 13 |
|
|
2017
Q3 | $8.44M | Buy |
95,000
+35,000
| +58% | +$2.66M | 2.87% | 5 |
|
|
2017
Q2 | $4.35M | Buy |
+60,000
| New | +$4.03M | 1.59% | 28 |
|
|
2016
Q4 | – | Sell |
-55,000
| Closed | -$3.47M | – | 55 |
|
|
2016
Q3 | $3.47M | Buy |
+55,000
| New | +$3.56M | 1.75% | 28 |
|
|
2014
Q4 | – | Sell |
-40,000
| Closed | -$2.31M | – | 65 |
|
|
2014
Q3 | $2.31M | Sell |
40,000
-45,000
| -53% | -$2.5M | 1.05% | 48 |
|
|
2014
Q2 | $4.8M | Buy |
85,000
+26,640
| +46% | +$1.4M | 2.42% | 12 |
|
|
2014
Q1 | $3M | Sell |
58,360
-1,640
| -3% | -$82.9K | 1.87% | 21 |
|
|
2013
Q4 | $3.17M | Buy |
+60,000
| New | +$2.95M | 2.25% | 15 |
|
Other funds holding ABBV
Sivik Global Healthcare's ABBV Position: Q2 2026 in Review
Sivik Global Healthcare held its AbbVie (ABBV) position steady in Q2 2026 at 15,000 shares worth $3.26M. The position accounts for 2.48% of the portfolio, ranked #22.
Sivik Global Healthcare first reported a position in ABBV in Q4 2013 and has held it in 22 quarters since. The position peaked at $8.44M in Q3 2017. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Sivik Global Healthcare held 15,000 shares of AbbVie worth $3.26M as of Q2 2026.
- Sivik Global Healthcare left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 2.48% of Sivik Global Healthcare's portfolio in Q2 2026, its #22 holding.
- Sivik Global Healthcare first reported a position in AbbVie in Q4 2013 and has held it in 22 quarters since.
- Sivik Global Healthcare's AbbVie position peaked at $8.44M in Q3 2017.
- 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.